ArticleMaterials today. Bio2020

Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy.

M R Landry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.